Table 1.
Characteristics of the study population
Number of patients | Missing data | Mean | Median | Maximum | Minimum | |
Race | 233 | 0 | ||||
Black | 41 | |||||
Hispanic | 22 | |||||
Asian | 4 | |||||
White | 166 | |||||
Age of diagnosis (years) | 233 | 0 | 63.48 | 63 | 84 | 42 |
≤65 | 137 | |||||
>65 | 96 | |||||
Gleason grade | 231 | 2 | ||||
≤6 | 28 | |||||
7–8 | 111 | |||||
≥9 | 92 | |||||
TNM stage | 216 | 17 | ||||
≤2 | 97 | |||||
≥3 | 119 | |||||
PSA at diagnosis | 227 | 6 | 76.56 | 12.7 | 3602 | 1 |
BMI, kg/m2 | 226 | 7 | 31 | 30.30 | 55.61 | 18.80 |
<30 | 105 | |||||
30–35 | 64 | |||||
>35 | 57 |
TNM, tumour–node–metastasis; PSA, prostate-specific antigen; BMI, body mass index.